--- title: "Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme" ocid: "ocds-kuma6s-132373" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-132373" markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-132373.md" json_url: "https://d3tenders.com/contract/ocds-kuma6s-132373.json" source: "Sell2Wales" current_stage: "Award" buyer: "NHS WALES SHARED SERVICES PARTNERSHIP" published: "2024-06-13" --- # Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme Buyer: NHS WALES SHARED SERVICES PARTNERSHIP Current stage: Award OCID: ocds-kuma6s-132373 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-132373) [Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-132373.json) ## Summary The NHS Wales Shared Services Partnership, based in Cardiff, UK, has conducted a procurement process for consultancy work to evaluate the all-Wales Suspected Cancer Pathway Programme. The project aims to transform cancer patient pathways through various initiatives aligned with the Suspected Cancer Pathway metric. The tender, now at the award stage, is focused on services and has a contract value of £99,920 GBP, with the contract being signed on 18th December 2023. The deadline for submission was on 4th July 2023. This tender offers business growth opportunities for consultancy firms with expertise in healthcare evaluation projects. Businesses with experience in health sector transformations, innovation in patient pathways, and value-based health care approaches are well-suited to compete. The procurement method used is an open procedure, providing an accessible platform for businesses to engage with the NHS Wales Shared Services Partnership's initiative to enhance cancer care pathways for better patient outcomes across Wales. ## Notice NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways ### Lot Information Lot 1 NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways ## Key Details | Field | Value | | --- | --- | | Publication source | Sell2Wales | | Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=132373 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 13 Jun 2024 | | Submission deadline | 4 Jul 2023 | | Future notice date | Not specified | | Award date | 18 Dec 2023 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £100,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £99,920 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Not specified | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP | | Locality | CARDIFF | | Post town | Cardiff | | Postcode | CF14 4TT | | Country | Wales | | ITL 1 | TLL Wales | | ITL 2 | TLL5 South East Wales | | ITL 3 | TLL51 Central Valleys and Bridgend | | Local authority | Rhondda Cynon Taf | | Electoral ward | Taff's Well | | Westminster constituency | Cardiff North | | Delivery location | TLL22 Cardiff and Vale of Glamorgan | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | CARNALL FARRAR | ## CPV Codes ### Divisions - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 79419000 - Evaluation consultancy services ## Release History - 13 Jun 2024 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=132373 - 14 Jun 2023 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=132373 ## Documents - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JUN440702 Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme - NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JUN480883 Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme - NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways ## Notice URLs - http://NWSSP.Cardiff.Procurement@wales.nhs.uk - http://www.procurement.wales.nhs.uk - http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=65818 - http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=68368 - https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-132373 - https://etenderwales.bravosolution.co.uk/home.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-132373. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-132373.json.